Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34


Journal

Experimental hematology
ISSN: 1873-2399
Titre abrégé: Exp Hematol
Pays: Netherlands
ID NLM: 0402313

Informations de publication

Date de publication:
03 2019
Historique:
received: 10 10 2018
revised: 23 12 2018
accepted: 30 12 2018
pubmed: 8 1 2019
medline: 7 5 2019
entrez: 8 1 2019
Statut: ppublish

Résumé

We describe the establishment of an embryoid-body-based protocol for hematopoietic/myeloid differentiation of human induced pluripotent stem cells that allows the generation of CD34

Identifiants

pubmed: 30615903
pii: S0301-472X(19)30004-9
doi: 10.1016/j.exphem.2018.12.006
pii:
doi:

Substances chimiques

Antigens, CD34 0
Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

51-60

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Auteurs

Benjamin Dannenmann (B)

Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany.

Azadeh Zahabi (A)

Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany.

Perihan Mir (P)

Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.

Benedikt Oswald (B)

Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany.

Regine Bernhard (R)

Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany.

Maksim Klimiankou (M)

Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany.

Tatsuya Morishima (T)

Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany.

Klaus Schulze-Osthoff (K)

German Cancer Research Center (DKFZ), Heidelberg, Germany; Interfaculty Institute of Biochemistry, Tübingen University, Germany.

Cornelia Zeidler (C)

Department of Hematology, Oncology, and Bone Marrow Transplantation, Hannover Medical School, Hannover, Germany.

Lothar Kanz (L)

Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany.

Nico Lachmann (N)

Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.

Thomas Moritz (T)

Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.

Karl Welte (K)

University Children's Hospital Tuebingen, Tuebingen, Germany.

Julia Skokowa (J)

Department of Oncology, Hematology, Immunology, Rheumatology, and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany. Electronic address: julia.skokowa@med.uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH